Press Release – August 19, 2011
Although the FDA approved the Melanoma drug PLX 4032 (Zelboraf) on Wednesday (August 17, 2011), what is not in the news is that the FDA is responsible for lives lost by not allowing access two years or more ago to this drug for people who were fighting for their lives and could not get into clinical trials for this efficacious drug. This is nothing less than another clear avoidable FDA tragedy.
The Abigail Alliance for Better Access to Developmental Drugs first started pushing for earlier access to PLX 4032 two years ago. The Abigail Alliance keeps working to gain wider attention to the clear proof of the lifesaving and life-extending need for earlier access to promising developmental drugs.
This is the profound proof. Every drug for cancer and other serious life-threatening illnesses that the Abigail Alliance has pushed for earlier access to in our ten-year history is now approved by the FDA! There is not one drug that we pushed for earlier access to that did not make it through the clinical trial process.
The current count is 19 drugs and vaccines! EVEN the FDA’s own Science and Technology Board in their late 2007 report recommended there be a provisional approval mechanism for promising new drugs.
-Frank Burroughs, Founder and Steve Walker, Cofounder
Abigail Alliance for Better Access to Developmental Drugs